Second-line therapy for advanced pancreatic cancer: A review of the literature and future directions☆
To access this article, please choose from the options below
☆ Center affiliate to the “Red Temática de Investigación Cooperativa (RD06/0020/0021)” and Programme “Acción Transversal del Cáncer”. Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation.
PII: S0305-7372(09)00126-1
doi:10.1016/j.ctrv.2009.08.012
© 2009 Elsevier Ltd. All rights reserved.
